Citation Impact
Citing Papers
The liver in hereditary haemorrhagic teleangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal.
1978
Hallmarks of Cancer: The Next Generation
2011 Standout
Neuroanatomic Correlates of Psychopathologic Components of Major Depressive Disorder
2005
Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour
2015
Cancer immunoediting: from immunosurveillance to tumor escape
2002 Standout
Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study
2003
Testicular Germ-Cell Cancer
1997 Standout
Cancer Immunosurveillance and Immunoediting: The Roles of Immunity in Suppressing Tumor Development and Shaping Tumor Immunogenicity
2006
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
2000 Standout
Clinical experience with the integral photodynamic theraphy of bladder carcinoma
1990
Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder
1995
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Natural History of Progression After PSA Elevation Following Radical Prostatectomy
1999 Standout
The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder
1990
Noninvasive Detection of Clinically Occult Lymph-Node Metastases in Prostate Cancer
2003 Standout
Hereditary Hemorrhagic Telangiectasia
1995 Standout
Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies
2001
Cancer Volume of Lymph Node Metastasis Predicts Progression in Prostate Cancer
1998
Clinical stage i nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone
1988
Photodynamic therapy for cancer
2003 Standout
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Induction of angiogenesis during the transition from hyperplasia to neoplasia
1989 StandoutNature
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
1991 Standout
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid
1994
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder
1995
Superficial Bladder Cancer: Progression and Recurrence
1983
Endoscopic image analysis of photosensitizer fluorescence as a promising noninvasive approach for pathological grading of bladder cancer in situ
2008
Bladder cancer
2016 Standout
Immunity, Inflammation, and Cancer
2010 Standout
The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder
1998 Standout
Phase II Trial of Debulking Surgery and Photodynamic Therapy for Disseminated Intraperitoneal Tumors
2001
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
2011 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer
1994
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
1991 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Prognostic factors in clinical stage I nonseminomatous germ cell tumors of the testis: multivariate analysis of a prospective multicenter study. Swedish-Norwegian Testicular Cancer Group.
1990
Major Depressive Disorder
2008 Standout
Hepatic involvement in hereditary hemorrhagic telangiectasia: Clinical, radiological, and hemodynamic studies of 11 cases
1993
Photodynamic therapy of cancer: An update
2011 Standout
Long‐Term Experience with Integral Photodynamic Therapy of TIS Bladder Carcinoma
2007
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
2012 StandoutNatureNobel
Photodynamic therapy of nonresectable cholangiocarcinoma
1998
Photodynamic therapy in urology: What can we do now and where are we heading?
2012
Bladder cancer: Epidemiology, staging and grading, and diagnosis
2005 Standout
Natural History and Treatment of Low and High Risk Superficial Bladder Tumors
1988
Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer
1991
Prognostic factors and outcome in patients with T1 high‐grade bladder cancer: can we identify patients for early cystectomy?
2011
The pathology of bladder cancer
2006
Incidence, Location, and Significance of Periprostatic and Periseminal Vesicle Lymph Nodes in Prostate Cancer
2001
In Vitro Approaches to the Mechanism of Cell-Mediated Immune Reactions
1971
Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium
2006
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
A Comparison of Hexaminolevulinate Fluorescence Cystoscopy and White Light Cystoscopy for the Detection of Carcinoma In Situ in Patients With Bladder Cancer: A Phase III, Multicenter Study
2007
Intracranial germ-cell tumors: natural history and pathogenesis
1985 Standout
Staging Pelvic Lymphadenectomy for Carcinoma of the Prostate: Risk Versus Benefit
1980
Mechanisms of Cell Protection by Heme Oxygenase-1
2010 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
PHOTODYNAMIC THERAPY USING PORFIMER SODIUM AS AN ALTERNATIVE TO CYSTECTOMY IN PATIENTS WITH REFRACTORY TRANSITIONAL CELL CARCINOMA IN SITU OF THE BLADDER
1998
Investigative Urology: Biodistribution and Phototoxicity of 5-Aminolevulinic Acid-Induced PpIX in an Orthotopic Rat Bladder Tumor Model
1995
PD-L1/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells
2004 StandoutNobel
Urothelial dysplasia and carcinomain situ of the bladder
1986
Transrectal ultrasound in the diagnosis of prostate cancer: Location, echogenicity, histopathology, and staging
1985
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
SEXUALLY TRANSMITTED PROTOZOAL INFECTIONS
1992
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Prognosis of Untreated Stage A1 Prostatic Carcinoma: A Study of 94 Cases with Extended Followup
1986
Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder
1980
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
2008 StandoutNobel
Disease Tolerance as a Defense Strategy
2012 StandoutScience
Evolution of the Management of Stage I Nonseminomatous Germ-cell Tumors of the Testis
1991
Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors
1993
Differential cell photosensitivity following porphyrin photodynamic therapy.
1988
Clinical manifestations of hereditary hemorrhagic telangiectasia.
1984
The pathogenesis of cancer metastasis
1980 StandoutNature
BODIPY dyes in photodynamic therapy
2012 Standout
Prognostic Factors in Men with Stage D1 Prostate Cancer: Identification of Patients Less Likely to Have Prolonged Survival After Radical Prostatectomy
1994
Intraperitoneal Cisplatin with Systemic Thiosulfate Protection
1982
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Photodynamic Therapy: Oncologic Horizons
2013
Prognostic Significance of Biopsy Results of Normal‐looking Mucosa in Cases of Superficial Bladder Cancer
1983
The History of Photodetection and Photodynamic Therapy¶
2001
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
2010 Standout
Neurological manifestations of hereditary hemorrhagic telangiectasia (rendu‐osler‐weber disease): Report of 2 cases and review of the literature
1978
The pathogenesis of benign prostatic hyperplasia
1980 Standout
The syndrome of inappropriate secretion of antidiuretic hormone
1967 Standout
A pathological survey of intracranial Germinoma and Pinealoma in Japan
1980
Emerging Targets in Photopharmacology
2016 StandoutNobel
GENETIC CONTROL OF THYMUS-DERIVED CELL FUNCTION
1972 StandoutNobel
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
The Value of Testosterone Deprivation in Stage D1 Carcinoma of the Prostate
1988
Investigative Urology
1995
Mapping of the urinary bladder: Its impact on the concepts of bladder cancer
1979
Clinical and Microbiological Aspects ofTrichomonas vaginalis
1998 Standout
Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate Cancer
1994 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
THE PRODUCTION OF MIGRATION INHIBITION FACTOR BY B AND T CELLS OF THE GUINEA PIG
1973 StandoutNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Immunodepression and Malignancy
1976
Urothelial Dysplasia
1982
Detection of Early Bladder Cancer by 5-Aminolevulinic Acid Induced Porphyrin Fluorescence
1996
Biologic and antigenic similarity of virus-induced migration inhibition factor to conventional, lymphocyte-derived migration inhibition factor.
1975 StandoutNobel
Works of James Daly being referenced
ECT in bipolar and unipolar depression: differences in speed of response
2001
Pro-inflammatory complement activation by the Aβ peptide of Alzheimer’s disease is biologically significant and can be blocked by vaccinia virus complement control protein
1998
Photodynamic Therapy with Hematoporphyrin Derivative in the Treatment of Superficial Transitional-Cell Carcinoma of the Bladder
1987
Massive intravascular haemolysis with T‐activation and disseminated intravascular coagulation due to clostridial sepsis
2006
Difference in Effect of Dog Seminal Fluid and Human Seminal Fluid and Semen on In Vitro Survival of Trichomonas vaginalis
1990
Carcinoma of the Prostate and Lymphatic Metastases
1974
Nodal Involvement as A Prognostic Indicator in Patients with Prostatic Carcinoma
1980
The Effect of Intravesical Thio-tepa on Normal and Tumor Urothelium
1978
Hyponatræmia with Carcinoma of the Bronchus
1963
Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in “surveillance only” protocols
1985
In Vitro Uptake of3H Testosterone and its Conversion to Dihydrotestosterone by Prostatic Carcinoma and Other Tissues
1976
Long-Term Spontaneous Tumor Incidence in Neonatally Thymectomized Mice
1973
The liver in hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease)
1976
Survival of Trichomonas vaginalis in human semen.
1989
Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms
1983
Prognosis of Clinically Undiagnosed Prostatic Carcinoma and the Influence of Endocrine Therapy
1977
Ta and T1 Bladder Cancer: Location, Recurrence and Progression†
1982
Non-Invasive Papillary Carcinoma of the Bladder Associated with Carcinoma in Situ
1976
Local Plasmacytopoiesis in Delayed Hypersensitivity Reactions
1969
Ectopic pinealoma: an unusual clinical presentation and a histochemical comparison with a seminoma of the testis
1973
The Outcome of Conservative Treatment of Carcinoma in Situ of the Bladder
1987
Biopsy of Apparently Normal Urothelium in Patients with Bladder Carcinoma
1978